ID

34433

Description

Better Adherence With New Oral Anticoagulant in Atrial Fibrillation : Effectiveness of a Personalized Education Program; ODM derived from: https://clinicaltrials.gov/show/NCT02422602

Link

https://clinicaltrials.gov/show/NCT02422602

Keywords

  1. 1/17/19 1/17/19 -
  2. 3/4/20 3/4/20 - Christian Arras
  3. 3/5/20 3/5/20 - Sarah Riepenhausen
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 17, 2019

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Non-valvular Atrial Fibrillation NCT02422602

Eligibility Non-valvular Atrial Fibrillation NCT02422602

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
all patients treated with rivaroxaban chronically, (atrial fibrillation non-valvular under current amm) for less than one year whatever anti vitamin k treatment history
Description

ID.1

Data type

boolean

affiliate or beneficiary of a social security system.
Description

ID.2

Data type

boolean

patient who formulated its "does not oppose" to participate in this research
Description

ID.3

Data type

boolean

age higher than or equal to 18 years
Description

ID.4

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
opposition to participation
Description

ID.5

Data type

boolean

patient don't understand french language
Description

ID.6

Data type

boolean

patient does not have responsibility for the management of treatment (treatment administered by a nurse at home, or by caregivers)
Description

ID.7

Data type

boolean

tutorship or curatoship
Description

ID.8

Data type

boolean

law-protected patient
Description

ID.9

Data type

boolean

pregnant women or breast-feeding
Description

ID.10

Data type

boolean

Similar models

Eligibility Non-valvular Atrial Fibrillation NCT02422602

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
all patients treated with rivaroxaban chronically, (atrial fibrillation non-valvular under current amm) for less than one year whatever anti vitamin k treatment history
boolean
ID.2
Item
affiliate or beneficiary of a social security system.
boolean
ID.3
Item
patient who formulated its "does not oppose" to participate in this research
boolean
ID.4
Item
age higher than or equal to 18 years
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
opposition to participation
boolean
ID.6
Item
patient don't understand french language
boolean
ID.7
Item
patient does not have responsibility for the management of treatment (treatment administered by a nurse at home, or by caregivers)
boolean
ID.8
Item
tutorship or curatoship
boolean
ID.9
Item
law-protected patient
boolean
ID.10
Item
pregnant women or breast-feeding
boolean

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial